Jacob Ma-Weaver - 29 Aug 2024 Form 4 Insider Report for ARCA biopharma, Inc. (ORKA)

Role
Other*
Signature
Jacob Ma-Weaver
Issuer symbol
ORKA
Transactions as of
29 Aug 2024
Net transactions value
$0
Form type
4
Filing time
30 Aug 2024, 17:57:33 UTC
Previous filing
31 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABIO Stock option (right to buy) Other -6,000 -100% 0 29 Aug 2024 Common stock $13,853 $1.64 Direct F1, F2, F3
transaction ABIO Stock option (right to buy) Other -6,000 -100% 0 29 Aug 2024 Common stock $9,773 $2.32 Direct F2, F3
transaction ABIO Stock option (right to buy) Other -12,000 -100% 0 29 Aug 2024 Common stock $20,147 $2.27 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jacob Ma-Weaver is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 is filed by Jacob Ma-Weaver. Mr. Ma-Weaver, Funicular Funds, LP, and Cable Car Capital LLC may have been deemed to be members of a Section 13(d) group that may have been deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. Following the closing of the Issuer's business combination on August 29, 2024, the Reporting Person is no longer a Director of the Issuer and the group no longer holds more than 10% of its outstanding shares of Common Stock.
F2 Pursuant to the terms of the Issuer's business combination agreement, all outstanding Issuer incentive options were canceled, and the holders thereof received an amount in cash equal to the product obtained by multiplying (A) the excess of approximately $3.9489 over the exercise price per share of the Parent Common Stock underlying such Parent Option by (B) the number of shares of the Parent Common Stock underlying such Parent Option.
F3 The Reporting Person assigned the proceeds of the option cash-out transactions to Funicular Funds, LP.